Intrinsic Value of S&P & Nasdaq Contact Us

AC Immune S.A. ACIU NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • CH • USD

SharesGrow Score
52/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$7.00
+122.9%

Stock Statistics — ACIU

AC Immune S.A. (ACIU) has a market capitalization of $319.57M and trades at $3.14. The 52-week range is 1.43-4.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4.7, Earnings Per Share (EPS) of $-0.67, annual revenue of $3.57M.

The stock has a beta of 1.63, operates in the Healthcare sector.

Trading Data
Current Price$3.14
52-Week Range1.43-4
Volume212.7K
Avg Volume (30D)293.57K
Market Cap$319.57M
Beta (1Y)1.63
Company
IPO Date2016-09-23
Employees133
CEOAndrea Pfeifer
CountryCH
ExchangeNASDAQ Global Market
CurrencyUSD
ISINCH0329023102
CUSIPH00263105
Income (Latest Year)
Revenue$3.57M
Gross Profit$3.57M
EBITDA$-63.47M
Operating Income$-68.86M
Net Income$-67.28M
EPS$-0.67
EPS Diluted$-0.67
Shares Outstanding$100.75M
Balance Sheet (Latest Year)
Total Assets$154.43M
Current Assets$96.83M
Cash & ST Investments$91.52M
Total Liabilities$109.49M
Total Debt$4.55M
Net Debt$-22.28M
Total Equity$44.93M
Debt / Equity0.10
Valuation Ratios
P/E Ratio-4.7
P/S Ratio89.44
P/B Ratio7.11
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message